Tag: research
-
New glioblastoma imaging shows how tumour cells respond to treatment.
Innovative imaging technology and machine learning developed by our Future Leader, Dr Spencer Watson, helps us understand how glioblastomas respond to treatment.
-
Dabrafenib and trametinib – NICE guidance published
The guidelines recently published by NICE mean that NHS England will be using dabrafenib and trametinib – the first ever targeted treatment for childhood brain tumours – to treat children whose tumours have a BRAF V600E mutation.
-
The Ways Ahead project – finding better ways to support people with their diagnosis
The Ways Ahead project aims to find ways to support, and improve quality of life for those diagnosed with a lower-grade brain tumour. It also explores ways to help friends and family who are supporting those diagnosed.
-
Expanding Theories Funding Announcement!
We are pleased to announce the two researchers who have been awarded our latest Expanding Theories grant!
-
BRAF mutations in childhood brain tumours
Research that we funded nearly 20 years ago laid the foundations for last week’s approval of dabrafenib and trametinib to treat childhood gliomas.
-
The ARISTOCRAT clinical trial – perspective from a patient advocate
Peter Buckle is a patient advocate and has worked with several teams, including the ARISTOCRAT team to champion research and clinical trials.
-
“It changes everything” – the impact of living with a lower-grade glioma
Living with a lower-grade glioma has a profound impact on those diagnosed, and their families. This is well documented anecdotally but needs to be scientifically addressed so that everyone affected by a brain tumour diagnosis gets the help and support they need.
-
Nanotechnology could help understand how glioblastomas respond to treatment
A new nanosurgical tool – about 500 times thinner than a human hair – could help us understand how glioblastomas become resistant to radio- and chemotherapy. Up until now, no other technology has been able to do this.
-
Finding new drugs for treating glioblastoma
In 2019, we awarded £2.96 million to Professor Neil Carragher in collaboration with Cancer Research UK as part of £6 million of funding for vital research into glioblastoma.
-
Future Leader presents her work at the world’s largest neuro-oncology conference
Dr Veronica Rendo, a researcher funded by The Brain Tumour Charity, shared the findings of her work at the annual meeting of the Society for Neuro-Oncology.
-
The Cancer Tech Accelerator
We are pleased to announce that The Brain Tumour Charity has joined the Cancer Tech Accelerator 3.0 as a new funding partner!
-
Dabrafenib and trametinib – a new treatment on the horizon?
Recent research suggests that there could be a new treatment on the horizon for some children diagnosed with low and high-grade gliomas.
-
Celebrating our award-winning researchers
Two of our funded researchers have won awards at the Society for Immunotherapy of Cancer (SITC) annual conference!
-
Collaborating for change at the NICE conference 2023
We recently attended the NICE 2023 conference and share some of the key takeaways we gathered from the event.
-
“Carpe Diem, that motto is important to me. I live in the moment”
Natalie McKenna-Mounty was diagnosed with a glioblastoma in 2020, her tumour returned in June this year, and now she is supporting our new research funding to find better glioblastoma treatments.
-
Future Leaders: Junior Fellowship Funding Announcement
We are pleased to announce the two researchers who have been awarded the Junior Fellowship grant – the second award in our Future Leaders programme!
-
Life-changing treatment means Zac lives a relatively normal life
Zachery Eckworth, now 11 years and living in Hampshire, was just 14 months old when we was diagnosed with an optic nerve glioma.
-
Quest for Cures funding announcement
We are pleased to announce that we have awarded £4.5 million to three new, exciting research initiatives.
-
Widening the debate around treatment
We praise the launch of OurBrainBank’s new policy report and share how it ties in with our research strategy and innovations around treatment for glioblastomas.
-
The Oli Hilsdon Foundation smashes fundraising goal 18 months early!
We’re driving forward cutting-edge research together, as the Foundation fulfils a ground-breaking new £1.5 million research grant 18 months early.
-
Key biomarker for aggressive meningiomas identified by researchers
Researchers at the University of Toronto have identified a biomarker that can predict how aggressive meningiomas may be in those diagnosed with this type of brain tumour.
-
Scientists join forces to transform treatments for childhood brain tumours
Experts at The Everest Centre are delivering a cutting-edge program of scientific research to develop pioneering new treatments for children diagnosed with low-grade brain tumours, following major new funding from The Brain Tumour Charity.
-
Lifestyle coaching may help reduce fatigue and improve mental health for those with a brain tumour.
Offering coaching to promote healthy lifestyles could help reduce severe fatigue for patients following brain tumour treatment, a clinical trial has found.
-
Pioneering new cancer vaccine planned in England
The government have signed an agreement with German pharmaceutical company BioNTech to ensure their innovative vaccine research comes to England.